 | • レポートコード：MRC2-11QY01443 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はハンチントン病治療薬のグローバル市場について調査・分析したレポートです。種類別（抗ドーパミン作動薬、抗けいれん薬、抗精神病薬、抗うつ薬）市場規模、用途別（病院、診療所、診断センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ハンチントン病治療薬の競争状況、市場シェア ・世界のハンチントン病治療薬市場：種類別市場規模 2015年-2020年（抗ドーパミン作動薬、抗けいれん薬、抗精神病薬、抗うつ薬） ・世界のハンチントン病治療薬市場：種類別市場規模予測 2021年-2026年（抗ドーパミン作動薬、抗けいれん薬、抗精神病薬、抗うつ薬） ・世界のハンチントン病治療薬市場：用途別市場規模 2015年-2020年（病院、診療所、診断センター） ・世界のハンチントン病治療薬市場：用途別市場規模予測 2021年-2026年（病院、診療所、診断センター） ・北米のハンチントン病治療薬市場分析：米国、カナダ ・ヨーロッパのハンチントン病治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのハンチントン病治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のハンチントン病治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのハンチントン病治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：F. Hoffmann-La Roche、H. Lundbeck、Prana Biotechnology、Teva Pharmaceutical Industries、Horizon Pharma ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Huntington’s disease is an inherited disease that causes degeneration of nerve cells in the central nervous system (CNS). The disease has a broad impact on functional abilities of the human and usually results in movement and thinking disabilities. Most people with Huntington’s disease develop signs and symptoms in their age of 30 to 40. When disease begins before age 20, the condition is known as juvenile Huntington’s disease.
The demand for Huntington’s disease (HD) therapeutics as one of the primary growth factors for the Huntington’s disease therapeutics market. HD is equally prevalent in both males and females and affects people irrespective of their ethnicity. The disease symptoms may appear anytime in the individual’s life and the etiology is genetic. The person who inherits the mutated genes from their affected parents will probably suffer from the disease sometime in their lifetime.
Market Analysis and Insights: Global Huntington’s Disease Therapeutics Market
The global Huntington’s Disease Therapeutics market size is projected to reach US$ 300.3 million by 2026, from US$ 227.3 million in 2020, at a CAGR of 29.8%% during 2021-2026.
Global Huntington’s Disease Therapeutics Scope and Market Size
Huntington’s Disease Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Huntington’s Disease Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Huntington’s Disease Therapeutics market is segmented into
Antidopaminergics
Anticonvulsants
Antipsychotics
Antidepressants
Segment by Application, the Huntington’s Disease Therapeutics market is segmented into
Hospitals
Clinics
Diagnostic Centers
Regional and Country-level Analysis
The Huntington’s Disease Therapeutics market is analysed and market size information is provided by regions (countries).
The key regions covered in the Huntington’s Disease Therapeutics market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Huntington’s Disease Therapeutics Market Share Analysis
Huntington’s Disease Therapeutics market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Huntington’s Disease Therapeutics business, the date to enter into the Huntington’s Disease Therapeutics market, Huntington’s Disease Therapeutics product introduction, recent developments, etc.
The major vendors covered:
F. Hoffmann-La Roche
H. Lundbeck
Prana Biotechnology
Teva Pharmaceutical Industries
Horizon Pharma
…
1 Study Coverage
1.1 Huntington’s Disease Therapeutics Product Introduction
1.2 Market Segments
1.3 Key Huntington’s Disease Therapeutics Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Huntington’s Disease Therapeutics Market Size Growth Rate by Type
1.4.2 Antidopaminergics
1.4.3 Anticonvulsants
1.4.4 Antipsychotics
1.4.5 Antidepressants
1.5 Market by Application
1.5.1 Global Huntington’s Disease Therapeutics Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Diagnostic Centers
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Huntington’s Disease Therapeutics Market Size, Estimates and Forecasts
2.1.1 Global Huntington’s Disease Therapeutics Revenue 2015-2026
2.1.2 Global Huntington’s Disease Therapeutics Sales 2015-2026
2.2 Global Huntington’s Disease Therapeutics, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Huntington’s Disease Therapeutics Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Huntington’s Disease Therapeutics Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Huntington’s Disease Therapeutics Competitor Landscape by Players
3.1 Huntington’s Disease Therapeutics Sales by Manufacturers
3.1.1 Huntington’s Disease Therapeutics Sales by Manufacturers (2015-2020)
3.1.2 Huntington’s Disease Therapeutics Sales Market Share by Manufacturers (2015-2020)
3.2 Huntington’s Disease Therapeutics Revenue by Manufacturers
3.2.1 Huntington’s Disease Therapeutics Revenue by Manufacturers (2015-2020)
3.2.2 Huntington’s Disease Therapeutics Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Huntington’s Disease Therapeutics Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Huntington’s Disease Therapeutics Revenue in 2019
3.2.5 Global Huntington’s Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Huntington’s Disease Therapeutics Price by Manufacturers
3.4 Huntington’s Disease Therapeutics Manufacturing Base Distribution, Product Types
3.4.1 Huntington’s Disease Therapeutics Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Huntington’s Disease Therapeutics Product Type
3.4.3 Date of International Manufacturers Enter into Huntington’s Disease Therapeutics Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Huntington’s Disease Therapeutics Market Size by Type (2015-2020)
4.1.1 Global Huntington’s Disease Therapeutics Sales by Type (2015-2020)
4.1.2 Global Huntington’s Disease Therapeutics Revenue by Type (2015-2020)
4.1.3 Huntington’s Disease Therapeutics Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Huntington’s Disease Therapeutics Market Size Forecast by Type (2021-2026)
4.2.1 Global Huntington’s Disease Therapeutics Sales Forecast by Type (2021-2026)
4.2.2 Global Huntington’s Disease Therapeutics Revenue Forecast by Type (2021-2026)
4.2.3 Huntington’s Disease Therapeutics Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Huntington’s Disease Therapeutics Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Huntington’s Disease Therapeutics Market Size by Application (2015-2020)
5.1.1 Global Huntington’s Disease Therapeutics Sales by Application (2015-2020)
5.1.2 Global Huntington’s Disease Therapeutics Revenue by Application (2015-2020)
5.1.3 Huntington’s Disease Therapeutics Price by Application (2015-2020)
5.2 Huntington’s Disease Therapeutics Market Size Forecast by Application (2021-2026)
5.2.1 Global Huntington’s Disease Therapeutics Sales Forecast by Application (2021-2026)
5.2.2 Global Huntington’s Disease Therapeutics Revenue Forecast by Application (2021-2026)
5.2.3 Global Huntington’s Disease Therapeutics Price Forecast by Application (2021-2026)
6 North America
6.1 North America Huntington’s Disease Therapeutics by Country
6.1.1 North America Huntington’s Disease Therapeutics Sales by Country
6.1.2 North America Huntington’s Disease Therapeutics Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Huntington’s Disease Therapeutics Market Facts & Figures by Type
6.3 North America Huntington’s Disease Therapeutics Market Facts & Figures by Application
7 Europe
7.1 Europe Huntington’s Disease Therapeutics by Country
7.1.1 Europe Huntington’s Disease Therapeutics Sales by Country
7.1.2 Europe Huntington’s Disease Therapeutics Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Huntington’s Disease Therapeutics Market Facts & Figures by Type
7.3 Europe Huntington’s Disease Therapeutics Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Huntington’s Disease Therapeutics by Region
8.1.1 Asia Pacific Huntington’s Disease Therapeutics Sales by Region
8.1.2 Asia Pacific Huntington’s Disease Therapeutics Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Huntington’s Disease Therapeutics Market Facts & Figures by Type
8.3 Asia Pacific Huntington’s Disease Therapeutics Market Facts & Figures by Application
9 Latin America
9.1 Latin America Huntington’s Disease Therapeutics by Country
9.1.1 Latin America Huntington’s Disease Therapeutics Sales by Country
9.1.2 Latin America Huntington’s Disease Therapeutics Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Huntington’s Disease Therapeutics Market Facts & Figures by Type
9.3 Central & South America Huntington’s Disease Therapeutics Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Huntington’s Disease Therapeutics by Country
10.1.1 Middle East and Africa Huntington’s Disease Therapeutics Sales by Country
10.1.2 Middle East and Africa Huntington’s Disease Therapeutics Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Huntington’s Disease Therapeutics Market Facts & Figures by Type
10.3 Middle East and Africa Huntington’s Disease Therapeutics Market Facts & Figures by Application
11 Company Profiles
11.1 F. Hoffmann-La Roche
11.1.1 F. Hoffmann-La Roche Corporation Information
11.1.2 F. Hoffmann-La Roche Description and Business Overview
11.1.3 F. Hoffmann-La Roche Sales, Revenue and Gross Margin (2015-2020)
11.1.4 F. Hoffmann-La Roche Huntington’s Disease Therapeutics Products Offered
11.1.5 F. Hoffmann-La Roche Related Developments
11.2 H. Lundbeck
11.2.1 H. Lundbeck Corporation Information
11.2.2 H. Lundbeck Description and Business Overview
11.2.3 H. Lundbeck Sales, Revenue and Gross Margin (2015-2020)
11.2.4 H. Lundbeck Huntington’s Disease Therapeutics Products Offered
11.2.5 H. Lundbeck Related Developments
11.3 Prana Biotechnology
11.3.1 Prana Biotechnology Corporation Information
11.3.2 Prana Biotechnology Description and Business Overview
11.3.3 Prana Biotechnology Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Prana Biotechnology Huntington’s Disease Therapeutics Products Offered
11.3.5 Prana Biotechnology Related Developments
11.4 Teva Pharmaceutical Industries
11.4.1 Teva Pharmaceutical Industries Corporation Information
11.4.2 Teva Pharmaceutical Industries Description and Business Overview
11.4.3 Teva Pharmaceutical Industries Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Teva Pharmaceutical Industries Huntington’s Disease Therapeutics Products Offered
11.4.5 Teva Pharmaceutical Industries Related Developments
11.5 Horizon Pharma
11.5.1 Horizon Pharma Corporation Information
11.5.2 Horizon Pharma Description and Business Overview
11.5.3 Horizon Pharma Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Horizon Pharma Huntington’s Disease Therapeutics Products Offered
11.5.5 Horizon Pharma Related Developments
11.1 F. Hoffmann-La Roche
11.1.1 F. Hoffmann-La Roche Corporation Information
11.1.2 F. Hoffmann-La Roche Description and Business Overview
11.1.3 F. Hoffmann-La Roche Sales, Revenue and Gross Margin (2015-2020)
11.1.4 F. Hoffmann-La Roche Huntington’s Disease Therapeutics Products Offered
11.1.5 F. Hoffmann-La Roche Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Huntington’s Disease Therapeutics Market Estimates and Projections by Region
12.1.1 Global Huntington’s Disease Therapeutics Sales Forecast by Regions 2021-2026
12.1.2 Global Huntington’s Disease Therapeutics Revenue Forecast by Regions 2021-2026
12.2 North America Huntington’s Disease Therapeutics Market Size Forecast (2021-2026)
12.2.1 North America: Huntington’s Disease Therapeutics Sales Forecast (2021-2026)
12.2.2 North America: Huntington’s Disease Therapeutics Revenue Forecast (2021-2026)
12.2.3 North America: Huntington’s Disease Therapeutics Market Size Forecast by Country (2021-2026)
12.3 Europe Huntington’s Disease Therapeutics Market Size Forecast (2021-2026)
12.3.1 Europe: Huntington’s Disease Therapeutics Sales Forecast (2021-2026)
12.3.2 Europe: Huntington’s Disease Therapeutics Revenue Forecast (2021-2026)
12.3.3 Europe: Huntington’s Disease Therapeutics Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Huntington’s Disease Therapeutics Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Huntington’s Disease Therapeutics Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Huntington’s Disease Therapeutics Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Huntington’s Disease Therapeutics Market Size Forecast by Region (2021-2026)
12.5 Latin America Huntington’s Disease Therapeutics Market Size Forecast (2021-2026)
12.5.1 Latin America: Huntington’s Disease Therapeutics Sales Forecast (2021-2026)
12.5.2 Latin America: Huntington’s Disease Therapeutics Revenue Forecast (2021-2026)
12.5.3 Latin America: Huntington’s Disease Therapeutics Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Huntington’s Disease Therapeutics Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Huntington’s Disease Therapeutics Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Huntington’s Disease Therapeutics Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Huntington’s Disease Therapeutics Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Huntington’s Disease Therapeutics Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Huntington’s Disease Therapeutics Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Huntington's Disease Therapeutics Market Segments
Table 2. Ranking of Global Top Huntington's Disease Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Huntington's Disease Therapeutics Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Antidopaminergics
Table 5. Major Manufacturers of Anticonvulsants
Table 6. Major Manufacturers of Antipsychotics
Table 7. Major Manufacturers of Antidepressants
Table 8. Global Huntington's Disease Therapeutics Market Size Growth Rate by Application 2020-2026 (K MT)
Table 9. Global Huntington's Disease Therapeutics Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 10. Global Huntington's Disease Therapeutics Sales by Regions 2015-2020 (K MT)
Table 11. Global Huntington's Disease Therapeutics Sales Market Share by Regions (2015-2020)
Table 12. Global Huntington's Disease Therapeutics Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Huntington's Disease Therapeutics Sales by Manufacturers (2015-2020) (K MT)
Table 14. Global Huntington's Disease Therapeutics Sales Share by Manufacturers (2015-2020)
Table 15. Global Huntington's Disease Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Huntington's Disease Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Huntington's Disease Therapeutics as of 2019)
Table 17. Huntington's Disease Therapeutics Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Huntington's Disease Therapeutics Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Huntington's Disease Therapeutics Price (2015-2020) (USD/MT)
Table 20. Huntington's Disease Therapeutics Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Huntington's Disease Therapeutics Product Type
Table 22. Date of International Manufacturers Enter into Huntington's Disease Therapeutics Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Huntington's Disease Therapeutics Sales by Type (2015-2020) (K MT)
Table 25. Global Huntington's Disease Therapeutics Sales Share by Type (2015-2020)
Table 26. Global Huntington's Disease Therapeutics Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Huntington's Disease Therapeutics Revenue Share by Type (2015-2020)
Table 28. Huntington's Disease Therapeutics Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 29. Global Huntington's Disease Therapeutics Sales by Application (2015-2020) (K MT)
Table 30. Global Huntington's Disease Therapeutics Sales Share by Application (2015-2020)
Table 31. North America Huntington's Disease Therapeutics Sales by Country (2015-2020) (K MT)
Table 32. North America Huntington's Disease Therapeutics Sales Market Share by Country (2015-2020)
Table 33. North America Huntington's Disease Therapeutics Revenue by Country (2015-2020) (US$ Million)
Table 34. North America Huntington's Disease Therapeutics Revenue Market Share by Country (2015-2020)
Table 35. North America Huntington's Disease Therapeutics Sales by Type (2015-2020) (K MT)
Table 36. North America Huntington's Disease Therapeutics Sales Market Share by Type (2015-2020)
Table 37. North America Huntington's Disease Therapeutics Sales by Application (2015-2020) (K MT)
Table 38. North America Huntington's Disease Therapeutics Sales Market Share by Application (2015-2020)
Table 39. Europe Huntington's Disease Therapeutics Sales by Country (2015-2020) (K MT)
Table 40. Europe Huntington's Disease Therapeutics Sales Market Share by Country (2015-2020)
Table 41. Europe Huntington's Disease Therapeutics Revenue by Country (2015-2020) (US$ Million)
Table 42. Europe Huntington's Disease Therapeutics Revenue Market Share by Country (2015-2020)
Table 43. Europe Huntington's Disease Therapeutics Sales by Type (2015-2020) (K MT)
Table 44. Europe Huntington's Disease Therapeutics Sales Market Share by Type (2015-2020)
Table 45. Europe Huntington's Disease Therapeutics Sales by Application (2015-2020) (K MT)
Table 46. Europe Huntington's Disease Therapeutics Sales Market Share by Application (2015-2020)
Table 47. Asia Pacific Huntington's Disease Therapeutics Sales by Region (2015-2020) (K MT)
Table 48. Asia Pacific Huntington's Disease Therapeutics Sales Market Share by Region (2015-2020)
Table 49. Asia Pacific Huntington's Disease Therapeutics Revenue by Region (2015-2020) (US$ Million)
Table 50. Asia Pacific Huntington's Disease Therapeutics Revenue Market Share by Region (2015-2020)
Table 51. Asia Pacific Huntington's Disease Therapeutics Sales by Type (2015-2020) (K MT)
Table 52. Asia Pacific Huntington's Disease Therapeutics Sales Market Share by Type (2015-2020)
Table 53. Asia Pacific Huntington's Disease Therapeutics Sales by Application (2015-2020) (K MT)
Table 54. Asia Pacific Huntington's Disease Therapeutics Sales Market Share by Application (2015-2020)
Table 55. Latin America Huntington's Disease Therapeutics Sales by Country (2015-2020) (K MT)
Table 56. Latin America Huntington's Disease Therapeutics Sales Market Share by Country (2015-2020)
Table 57. Latin Americaa Huntington's Disease Therapeutics Revenue by Country (2015-2020) (US$ Million)
Table 58. Latin America Huntington's Disease Therapeutics Revenue Market Share by Country (2015-2020)
Table 59. Latin America Huntington's Disease Therapeutics Sales by Type (2015-2020) (K MT)
Table 60. Latin America Huntington's Disease Therapeutics Sales Market Share by Type (2015-2020)
Table 61. Latin America Huntington's Disease Therapeutics Sales by Application (2015-2020) (K MT)
Table 62. Latin America Huntington's Disease Therapeutics Sales Market Share by Application (2015-2020)
Table 63. Middle East and Africa Huntington's Disease Therapeutics Sales by Country (2015-2020) (K MT)
Table 64. Middle East and Africa Huntington's Disease Therapeutics Sales Market Share by Country (2015-2020)
Table 65. Middle East and Africa Huntington's Disease Therapeutics Revenue by Country (2015-2020) (US$ Million)
Table 66. Middle East and Africa Huntington's Disease Therapeutics Revenue Market Share by Country (2015-2020)
Table 67. Middle East and Africa Huntington's Disease Therapeutics Sales by Type (2015-2020) (K MT)
Table 68. Middle East and Africa Huntington's Disease Therapeutics Sales Market Share by Type (2015-2020)
Table 69. Middle East and Africa Huntington's Disease Therapeutics Sales by Application (2015-2020) (K MT)
Table 70. Middle East and Africa Huntington's Disease Therapeutics Sales Market Share by Application (2015-2020)
Table 71. F. Hoffmann-La Roche Corporation Information
Table 72. F. Hoffmann-La Roche Description and Major Businesses
Table 73. F. Hoffmann-La Roche Huntington's Disease Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 74. F. Hoffmann-La Roche Product
Table 75. F. Hoffmann-La Roche Recent Development
Table 76. H. Lundbeck Corporation Information
Table 77. H. Lundbeck Description and Major Businesses
Table 78. H. Lundbeck Huntington's Disease Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 79. H. Lundbeck Product
Table 80. H. Lundbeck Recent Development
Table 81. Prana Biotechnology Corporation Information
Table 82. Prana Biotechnology Description and Major Businesses
Table 83. Prana Biotechnology Huntington's Disease Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 84. Prana Biotechnology Product
Table 85. Prana Biotechnology Recent Development
Table 86. Teva Pharmaceutical Industries Corporation Information
Table 87. Teva Pharmaceutical Industries Description and Major Businesses
Table 88. Teva Pharmaceutical Industries Huntington's Disease Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 89. Teva Pharmaceutical Industries Product
Table 90. Teva Pharmaceutical Industries Recent Development
Table 91. Horizon Pharma Corporation Information
Table 92. Horizon Pharma Description and Major Businesses
Table 93. Horizon Pharma Huntington's Disease Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 94. Horizon Pharma Product
Table 95. Horizon Pharma Recent Development
Table 96. Global Huntington's Disease Therapeutics Sales Forecast by Regions (2021-2026) (K MT)
Table 97. Global Huntington's Disease Therapeutics Sales Market Share Forecast by Regions (2021-2026)
Table 98. Global Huntington's Disease Therapeutics Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 99. Global Huntington's Disease Therapeutics Revenue Market Share Forecast by Regions (2021-2026)
Table 100. North America: Huntington's Disease Therapeutics Sales Forecast by Country (2021-2026) (K MT)
Table 101. North America: Huntington's Disease Therapeutics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 102. Europe: Huntington's Disease Therapeutics Sales Forecast by Country (2021-2026) (K MT)
Table 103. Europe: Huntington's Disease Therapeutics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 104. Asia Pacific: Huntington's Disease Therapeutics Sales Forecast by Region (2021-2026) (K MT)
Table 105. Asia Pacific: Huntington's Disease Therapeutics Revenue Forecast by Region (2021-2026) (US$ Million)
Table 106. Latin America: Huntington's Disease Therapeutics Sales Forecast by Country (2021-2026) (K MT)
Table 107. Latin America: Huntington's Disease Therapeutics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 108. Middle East and Africa: Huntington's Disease Therapeutics Sales Forecast by Country (2021-2026) (K MT)
Table 109. Middle East and Africa: Huntington's Disease Therapeutics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 110. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 111. Key Challenges
Table 112. Market Risks
Table 113. Main Points Interviewed from Key Huntington's Disease Therapeutics Players
Table 114. Huntington's Disease Therapeutics Customers List
Table 115. Huntington's Disease Therapeutics Distributors List
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Huntington's Disease Therapeutics Product Picture
Figure 2. Global Huntington's Disease Therapeutics Sales Market Share by Type in 2020 & 2026
Figure 3. Antidopaminergics Product Picture
Figure 4. Anticonvulsants Product Picture
Figure 5. Antipsychotics Product Picture
Figure 6. Antidepressants Product Picture
Figure 7. Global Huntington's Disease Therapeutics Sales Market Share by Application in 2020 & 2026
Figure 8. Hospitals
Figure 9. Clinics
Figure 10. Diagnostic Centers
Figure 11. Huntington's Disease Therapeutics Report Years Considered
Figure 12. Global Huntington's Disease Therapeutics Market Size 2015-2026 (US$ Million)
Figure 13. Global Huntington's Disease Therapeutics Sales 2015-2026 (K MT)
Figure 14. Global Huntington's Disease Therapeutics Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Huntington's Disease Therapeutics Sales Market Share by Region (2015-2020)
Figure 16. Global Huntington's Disease Therapeutics Sales Market Share by Region in 2019
Figure 17. Global Huntington's Disease Therapeutics Revenue Market Share by Region (2015-2020)
Figure 18. Global Huntington's Disease Therapeutics Revenue Market Share by Region in 2019
Figure 19. Global Huntington's Disease Therapeutics Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Huntington's Disease Therapeutics Revenue in 2019
Figure 21. Huntington's Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Huntington's Disease Therapeutics Sales Market Share by Type (2015-2020)
Figure 23. Global Huntington's Disease Therapeutics Sales Market Share by Type in 2019
Figure 24. Global Huntington's Disease Therapeutics Revenue Market Share by Type (2015-2020)
Figure 25. Global Huntington's Disease Therapeutics Revenue Market Share by Type in 2019
Figure 26. Global Huntington's Disease Therapeutics Market Share by Price Range (2015-2020)
Figure 27. Global Huntington's Disease Therapeutics Sales Market Share by Application (2015-2020)
Figure 28. Global Huntington's Disease Therapeutics Sales Market Share by Application in 2019
Figure 29. Global Huntington's Disease Therapeutics Revenue Market Share by Application (2015-2020)
Figure 30. Global Huntington's Disease Therapeutics Revenue Market Share by Application in 2019
Figure 31. North America Huntington's Disease Therapeutics Sales Growth Rate 2015-2020 (K MT)
Figure 32. North America Huntington's Disease Therapeutics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Huntington's Disease Therapeutics Sales Market Share by Country in 2019
Figure 34. North America Huntington's Disease Therapeutics Revenue Market Share by Country in 2019
Figure 35. U.S. Huntington's Disease Therapeutics Sales Growth Rate (2015-2020) (K MT)
Figure 36. U.S. Huntington's Disease Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Huntington's Disease Therapeutics Sales Growth Rate (2015-2020) (K MT)
Figure 38. Canada Huntington's Disease Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Huntington's Disease Therapeutics Market Share by Type in 2019
Figure 40. North America Huntington's Disease Therapeutics Market Share by Application in 2019
Figure 41. Europe Huntington's Disease Therapeutics Sales Growth Rate 2015-2020 (K MT)
Figure 42. Europe Huntington's Disease Therapeutics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Huntington's Disease Therapeutics Sales Market Share by Country in 2019
Figure 44. Europe Huntington's Disease Therapeutics Revenue Market Share by Country in 2019
Figure 45. Germany Huntington's Disease Therapeutics Sales Growth Rate (2015-2020) (K MT)
Figure 46. Germany Huntington's Disease Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Huntington's Disease Therapeutics Sales Growth Rate (2015-2020) (K MT)
Figure 48. France Huntington's Disease Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Huntington's Disease Therapeutics Sales Growth Rate (2015-2020) (K MT)
Figure 50. U.K. Huntington's Disease Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Huntington's Disease Therapeutics Sales Growth Rate (2015-2020) (K MT)
Figure 52. Italy Huntington's Disease Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Huntington's Disease Therapeutics Sales Growth Rate (2015-2020) (K MT)
Figure 54. Russia Huntington's Disease Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Huntington's Disease Therapeutics Market Share by Type in 2019
Figure 56. Europe Huntington's Disease Therapeutics Market Share by Application in 2019
Figure 57. Asia Pacific Huntington's Disease Therapeutics Sales Growth Rate 2015-2020 (K MT)
Figure 58. Asia Pacific Huntington's Disease Therapeutics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Huntington's Disease Therapeutics Sales Market Share by Region in 2019
Figure 60. Asia Pacific Huntington's Disease Therapeutics Revenue Market Share by Region in 2019
Figure 61. China Huntington's Disease Therapeutics Sales Growth Rate (2015-2020) (K MT)
Figure 62. China Huntington's Disease Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Huntington's Disease Therapeutics Sales Growth Rate (2015-2020) (K MT)
Figure 64. Japan Huntington's Disease Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Huntington's Disease Therapeutics Sales Growth Rate (2015-2020) (K MT)
Figure 66. South Korea Huntington's Disease Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Huntington's Disease Therapeutics Sales Growth Rate (2015-2020) (K MT)
Figure 68. India Huntington's Disease Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Huntington's Disease Therapeutics Sales Growth Rate (2015-2020) (K MT)
Figure 70. Australia Huntington's Disease Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Huntington's Disease Therapeutics Sales Growth Rate (2015-2020) (K MT)
Figure 72. Taiwan Huntington's Disease Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Huntington's Disease Therapeutics Sales Growth Rate (2015-2020) (K MT)
Figure 74. Indonesia Huntington's Disease Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Huntington's Disease Therapeutics Sales Growth Rate (2015-2020) (K MT)
Figure 76. Thailand Huntington's Disease Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Huntington's Disease Therapeutics Sales Growth Rate (2015-2020) (K MT)
Figure 78. Malaysia Huntington's Disease Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Huntington's Disease Therapeutics Sales Growth Rate (2015-2020) (K MT)
Figure 80. Philippines Huntington's Disease Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Huntington's Disease Therapeutics Sales Growth Rate (2015-2020) (K MT)
Figure 82. Vietnam Huntington's Disease Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Huntington's Disease Therapeutics Market Share by Type in 2019
Figure 84. Asia Pacific Huntington's Disease Therapeutics Market Share by Application in 2019
Figure 85. Latin America Huntington's Disease Therapeutics Sales Growth Rate 2015-2020 (K MT)
Figure 86. Latin America Huntington's Disease Therapeutics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Huntington's Disease Therapeutics Sales Market Share by Country in 2019
Figure 88. Latin America Huntington's Disease Therapeutics Revenue Market Share by Country in 2019
Figure 89. Mexico Huntington's Disease Therapeutics Sales Growth Rate (2015-2020) (K MT)
Figure 90. Mexico Huntington's Disease Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Huntington's Disease Therapeutics Sales Growth Rate (2015-2020) (K MT)
Figure 92. Brazil Huntington's Disease Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Huntington's Disease Therapeutics Sales Growth Rate (2015-2020) (K MT)
Figure 94. Argentina Huntington's Disease Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Huntington's Disease Therapeutics Market Share by Type in 2019
Figure 96. Latin America Huntington's Disease Therapeutics Market Share by Application in 2019
Figure 97. Middle East and Africa Huntington's Disease Therapeutics Sales Growth Rate 2015-2020 (K MT)
Figure 98. Middle East and Africa Huntington's Disease Therapeutics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Huntington's Disease Therapeutics Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Huntington's Disease Therapeutics Revenue Market Share by Country in 2019
Figure 101. Turkey Huntington's Disease Therapeutics Sales Growth Rate (2015-2020) (K MT)
Figure 102. Turkey Huntington's Disease Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Huntington's Disease Therapeutics Sales Growth Rate (2015-2020) (K MT)
Figure 104. Saudi Arabia Huntington's Disease Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Huntington's Disease Therapeutics Sales Growth Rate (2015-2020) (K MT)
Figure 106. U.A.E Huntington's Disease Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Huntington's Disease Therapeutics Market Share by Type in 2019
Figure 108. Middle East and Africa Huntington's Disease Therapeutics Market Share by Application in 2019
Figure 109. North America Huntington's Disease Therapeutics Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 110. North America Huntington's Disease Therapeutics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Europe Huntington's Disease Therapeutics Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 112. Europe Huntington's Disease Therapeutics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Asia Pacific Huntington's Disease Therapeutics Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 114. Asia Pacific Huntington's Disease Therapeutics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Latin America Huntington's Disease Therapeutics Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 116. Latin America Huntington's Disease Therapeutics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Middle East and Africa Huntington's Disease Therapeutics Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 118. Middle East and Africa Huntington's Disease Therapeutics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Porter's Five Forces Analysis
Figure 120. Channels of Distribution
Figure 121. Distributors Profiles
Figure 122. Bottom-up and Top-down Approaches for This Report
Figure 123. Data Triangulation
Figure 124. Key Executives Interviewed
ハンチントン病タンパク質の世界市場（～2026年） Market Analysis and Insights: Global Huntington Disease Protein Market The global Huntington Disease Protein market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Huntington Disease Protein Scope and Market Size Huntington D…- アルツハイマー病治療薬の世界市場（～2026年） Alzheimer’s disease is a neurodegenerative, progressive, non-reversible disorder. Alzheimer’s disease is caused due to abnormal functioning of brain cells i.e. failure of synaptic transmission, resulting in the loss of cognitive functions. Some of the signs and symptoms of alzheimer’s disease are me…
- 獣医感染症治療薬の世界市場（～2026年） Market Analysis and Insights: Global Veterinary Infectious Disease Therapeutics Market The global Veterinary Infectious Disease Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Veterinary Infectious Disease…
- 胃食道逆流症（GERD）治療薬の世界市場（～2026年） Gastroesophageal reflux disease (GERD), also known as acid reflux, is a long-term condition where stomach contents come back up into the esophagus resulting in either symptoms or complications. Patent expiry of blockbuster drugs prescribed for the treatment of acid reflux disorders is majorly attrib…
- 非アルコール性脂肪肝疾患治療薬の世界市場（～2026年） Nonalcoholic fatty liver disease (NAFLD) is a condition in which excessive fatty accumulation in the hepatocytes. There are two types of NAFLD, namely simple fatty liver and non-alcoholic steatohepatitis. In simple fatty liver, the fat in the liver is very less and there is no inflammation or liver …